Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing the Natriuretic Peptide System in HFpEF: A Randomized Double-Blind Placebo-Controlled Triple Crossover Study

NCT05279742 is registered in ClinicalTrials.gov with Horng Chen as lead sponsor.

NCT NCT05279742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing the Natriuretic Peptide System in HFpEF: A Randomized Double-Blind Placebo-Controlled Triple Crossover Study
Lead sponsor
Horng Chen
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
November 4, 2022
Completion date
April 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, heart failure with preserved ejection fraction